<DOC>
	<DOCNO>NCT02147379</DOCNO>
	<brief_summary>This 6 week , randomize , open-label , parallel group study patient Bipolar-I disorder ( manic depression ) , remission episode . Participants show cognitive impairment baseline randomize receive open-label Lurasidone add current medication ( ) continue usual treatment 6 week . Participants 3 clinical visit 2 telephone appointment study . Given preliminary evidence efficacy Lurasidone improve cognition schizophrenia , propose examine efficacy Lurasidone improve cognition bipolar patient .</brief_summary>
	<brief_title>Lurasidone Cognition Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<criteria>1 . All patient must take either lithium valproate one atypical antipsychotic mood stabilization . 2 . Patients show cognitive impairment ( 0.25 standard deviation ( SD ) ) either Trail Making Test trial B ( TMTB ) California Verbal Learning Test ( CVLT ) trials 1 5 , CVLT long delay free recall , baseline visit . 3 . Males female age 19 65 year inclusive . 4 . Diagnostic Statistical Manual IV edition ( DSMIV TR ) diagnosis Bipolar Type I Disorder , without history psychosis . 5 . Clinically stable Montgomery Asberg Depression Rating Scale ( MADRS ) Young Mania Rating Scale ( YMRS ) score less equal 8 . 6 . A sufficient level English use language screen questionnaire . 7 . Capability understanding , consent , comply requirement study . 1 . A history unstable inadequately treat medical illness , include moderate severe brain injury , neurological illness impact cognitive function . 2 . Treatment Electroconvulsive Therapy ( ECT ) within eight week prior enrolment ; treatment experimental drug within 30 day prior enrolment . 3 . Axis I diagnosis substance abuse dependence within past month . 4 . Significant risk harm self others , opinion investigator . 5 . Pregnancy lactation female subject . 6 . Liver function test ( AST ALT ) three time upper limit normal .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Cognition</keyword>
	<keyword>Euthymic</keyword>
	<keyword>Lurasidone</keyword>
</DOC>